Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity-Reference-Cited by-同舟云学术

Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity

Published:2016-11-14 Issue:3 Volume:81 Page:473-479
ISSN:0031-3998
Container-title:Pediatric Research
language:en
Short-container-title:Pediatr Res

Author:

Zepeda-Romero Luz Consuelo,Vazquez-Membrillo Miguel,Adan-Castro Elva,Gomez-Aguayo Francisco,Gutierrez-Padilla Jose Alfonso,Angulo-Castellanos Eusebio,Barrera de Leon Juan Carlos,Gonzalez-Bernal Cesareo,Quezada-Chalita Manuel Alejandro,Meza-Anguiano Alonso,Diaz-Lezama Nundehui,Martinez de la Escalera Gonzalo,Triebel Jakob,Clapp Carmen

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology, and Child Health

Link

http://www.nature.com/articles/pr2016241.pdf

Reference40 articles.

1. Friddle K. Pathogenesis of retinopathy of prematurity: Does inflamation play a role? Newborn Infant Nurs Rev 2013; 13:161–165.

2. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet 2013;382:1445–57.

3. Budd SJ, Hartnett ME. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity. Arch Ophthalmol 2010;128:589–95.

4. Harder BC, von Baltz S, Jonas JB, Schlichtenbrede FC. Intravitreal low-dosage bevacizumab for retinopathy of prematurity. Acta Ophthalmol 2014;92:577–81.

5. Sato T, Kusaka S, Shimojo H, Fujikado T. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 2009;116:1599–603.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating VEGF-A Levels in Relation to Retinopathy of Prematurity and Treatment Effects: A Systematic Review and Meta-Analysis;Ophthalmology Science;2024-11

2. Immunometric and functional measurement of endogenous vasoinhibin in human sera;Frontiers in Endocrinology;2024-04-29

3. Vasoinhibin’s Apoptotic, Inflammatory, and Fibrinolytic Actions Are in a Motif Different From Its Antiangiogenic HGR Motif;Endocrinology;2023-12-06

4. Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial;Eye;2023-09-06

5. The apoptotic, inflammatory, and fibrinolytic actions of vasoinhibin are in a motif different from its antiangiogenic HGR motif;2023-08-19